Hikal Signals Stronger H2, Maintains Full Year Guidance
After a challenging first half of FY26, Hikal Ltd is signalling confidence that second-half results will outperform H1, anchored on resumed supplies, capacity utilisation, and new product momentum. The diversified chemicals and life-sciences firm is holding to its full-year guidance, underscoring strategic resilience and improving demand visibility across segments. H1 performance and the H2 rebound […]
Hikal Signals Stronger H2, Maintains Full Year Guidance Read More »
